ACE and acute kidney injury: A study evaluating nephroprotective activity of quercetin against I/R and inhibition of RAAS pathway, performed a comparison between Lisinopril, losartan and quercetin and found that Lisinopril was a potent ACE inhibitor however, does not present protective effects against I/R-induced Acute Kidney Injury.